Literature DB >> 3578136

Altered lymphocyte subsets during cardiopulmonary bypass.

J I Brody, N J Pickering, G B Fink, E D Behr.   

Abstract

Peripheral blood lymphocyte subsets were quantified by immunofluorescence in nine patients undergoing open heart surgery for coronary artery, valvular, and congenital heart disease. Compared with normal preoperative values, all patients developed an absolute lymphopenia, a reduction in T4 (helper) lymphocytes, and a statistically significant reversal of the T4/T8 ratio two hours after cardiopulmonary bypass (CPB). These changes could be caused by mechanical or immunogenic injury. A return to normal of the T4 subset and T4/T8 proportion occurred 24 hours after surgery. Whereas transient inactivation of immunoreactive lymphocyte clones may prevent unwanted immunization to blood products received during surgery, such temporary immune dysfunction could make certain patients liable to infectious sequelae. Viral-induced postperfusion syndromes, transmission of human T lymphotropic virus (HTLV) III by blood products, and reports of acquired immune deficiency syndrome after CPB foster a concern regarding postoperative infections under these circumstances.

Entities:  

Mesh:

Year:  1987        PMID: 3578136     DOI: 10.1093/ajcp/87.5.626

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Coronary artery bypass graft in a renal transplant recipient.

Authors:  S Taketani; N Fukushima; S Ohtake; Y Sawa; M Nishimura; H Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-08

2.  Perioperative measurements of IL-6 and α-melanocyte stimulating hormone in a cardiac transplant patient after ventricular assist device support.

Authors:  T Sakai; A Kudoh; N Kotani; T W Latson; A H Giesecke; A Matsuki
Journal:  J Anesth       Date:  1995-03       Impact factor: 2.078

3.  Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.

Authors:  C Wenisch; A Bartunek; K Zedtwitz-Liebenstein; M Hiesmayr; B Parschalk; T Pernerstorfer; W Graninger
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

4.  Herpes simplex viral pneumonia after coronary artery bypass grafting.

Authors:  Ken-ichi Arata; Ryuzo Sakata; Yoshifumi Iguro; Riichiro Toda; Shun-Ichi Watanabe; Yoshito Eitsuru
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-04

5.  Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis.

Authors:  M Bofill; G Janossy; C A Lee; D MacDonald-Burns; A N Phillips; C Sabin; A Timms; M A Johnson; P B Kernoff
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

6.  Flow cytometric evaluation of T cell activation markers after cardiopulmonary bypass.

Authors:  Maja-Theresa Dieterlen; Hartmuth B Bittner; Attila Tarnok; Jens Garbade; Stefan Dhein; Friedrich W Mohr; Markus J Barten
Journal:  Surg Res Pract       Date:  2014-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.